ESC Premium Access

Is there a difference in outcome in patients undergoing first vs. second line ablation of atrial fibrillation?

Congress Presentation

About the speaker

Doctor Martin Manninger

Medical University of Graz, Graz (Austria)
2 presentations
0 follower

19 more presentations in this session

Personalized ablation strategy in patients with long-standing persistent atrial fibrillation and chronic heart failure.

Speaker: Doctor V. Orshanskaya (Saint Petersburg, RU)

Thumbnail

High-normal thyroid-stimulating hormone shows a potential causal association with arrhythmia recurrence after catheter ablation for atrial fibrillation

Speaker: Doctor I. Morishima (Ogaki, JP)

Thumbnail

Clinical impact of thyroxin levels on recurrence of atrial fibrillation after catheter ablation for patients without thyroid dysfunction: a multicenter study

Speaker: Doctor T. Yonishi (Osaka, JP)

Thumbnail

Improvement in quality of life in patients that underwent catheter ablation for persistent atrial fibrillation.

Speaker: Doctor K. Nakajima (Tokyo, JP)

Thumbnail

Association of coronary artery disease and revascularization with recurrence of atrial fibrillation after catheter ablation

Speaker: Doctor D. Hiraya (Ibaraki, JP)

Thumbnail

Access the full session

Poster Session 7 - Atrial fibrillation - Ablation

Speakers: Doctor M. Manninger, Doctor V. Orshanskaya, Doctor I. Morishima, Doctor T. Yonishi, Doctor K. Nakajima...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb